secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeneDx Holdings Corp. (WGS)
CIK:        0001818331
Form:       8-K
Filed at:   2023-02-14T23:59:59+00:00
Accession:  0001818331-23-000018
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

GeneDx director Dr. Michael Pellini resigns; Section 32 remains supporter after $150M financing
--------------------------------------------------------------------------------

- Dr. Michael Pellini stepped down from the Board effective February 14, 2023.
- Resignation to focus on his role as Managing Partner of Section 32, LLC.
- Pellini's departure not due to any disagreement with management or the Board.
- GeneDx thanked Section 32 for continued support and participation in January 2023 $150M equity financing.
- Company to evaluate whether to fill the vacancy or reduce board size.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818331/000181833123000018/0001818331-23-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818331/000181833123000018/smfr-20230214.htm
  HTML page:      https://secwatch.observer/filing/0001818331-23-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer